Insilico Medicine uses AI to discover novel SIK2 inhibitors

Insilico Medicine (“Insilico”), a clinical-stage end-to-end generative artificial intelligence (AI) drug discovery company, has achieved a significant breakthrough in the application of multiple generative AI models and AlphaFold structures for drug discovery.

Numinus Appoints New Chief Financial Officer | Psychedelic Invest

Numinus Wellness Inc. (TSX: NUMI / OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced the appointment of Nikhil Handa as

June 14, 2023

Fruit fly study provides insights into piRNA production and fertility

You’re likely familiar with RNA, the molecule that plays an important role in protein production and gene expression control.

August 10, 2023

Opinion | Are President Trump’s Executive Orders on Health Legal?

Wetter and Gostin are experts in health law and policy. Since taking office, President Trump has signed a barrage of executive orders taking aim at

March 7, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.